Professional Documents
Culture Documents
Ageloc Transformation
Ageloc Transformation
TRANSFORMATION
ageLOC POSITIONING
75%
66%
73%
70%
62%
71%
59%
56%
51%
50%
www.nuskin.com
isc
D
in
n
tio
ra
yd
(S
po
ts)
i ze
n
at
ol
or
ce
an
di
Ra
io
Po
r
eS
ne
ht
rig
(B
s/
ne
Li
ne
Fi
ss)
s
kle
W
rin
To
n
Sk
in
ne
en
th
Ev
oo
Sm
in
Sk
k in
St
ru
ct
ur
ss
25%
Sk
* Based upon results of a third-party clinical trial where subjects showed clinically proven,
visible results in all eight signs of aging in only seven days.
100%
Yo
u
lS
Benefits
Primary Market:
Women and men over 30 who are concerned with preventing and minimizing the signs of aging.
secondary market:
Skin-conscious women and men younger than 30 who are
concerned with the prevention of visible aging.
fu
Target Audience
th
TRANSFORMATION
USAGE
Morning Regimen
Step 1: ageLOC Gentle Cleanse & Tone
Step 2: ageLOC Future Serum*
Step 3: ageLOC Radiant Day SPF 22
Evening Regimen
Step 1: ageLOC Gentle Cleanse & Tone
Step 2: ageLOC Future Serum*
Step 3: ageLOC Transforming Night
ageLOC Transformation packages and instructions are
optimized for 30-day use.
* Additional treatment products may be added to this system.
For a more comprehensive approach, try Tru Face Essence
Ultra in addition to ageLOC Future Serum.
COMPLEMENTARY PRODUCTS
www.nuskin.com
TRANSFORMATION
smoothness. Designed specifically for the delicate eye
area, this anti-aging treatment ensures your eyes look
young, refreshed, and vibrant.
How does the new ageLOC science fit into the existing
Nu Skin portfolio?
ageLOC is a premier addition to the already exceptional
Nu Skin product offering. Nu Skin systems have been and
continue to be formulated with state-of-the-art technologies and ingredients. While previous Nu Skin systems were
formulated to target one or even multiple signs of aging,
ageLOC provides even greater anti-aging benefits by targeting the ultimate sources of aging. Many Nu Skin products such as Tru Face Essence Ultra are highly complementary to the ageLOC products and should still be used
in conjunction with ageLOC.